Filing Details
- Accession Number:
- 0000899243-19-012103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-03 20:58:13
- Reporting Period:
- 2019-05-03
- Accepted Time:
- 2019-05-03 20:58:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1217234 | Caredx Inc. | CDNA | Services-Medical Laboratories (8071) | 943316839 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1721150 | Sasha King | C/O Caredx, Inc. 3260 Bayshore Boulevard Brisbane CA 94005 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-03 | 833 | $5.90 | 77,427 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-03 | 417 | $6.31 | 77,844 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-03 | 1,250 | $29.50 | 76,594 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-05-03 | 833 | $0.00 | 833 | $5.90 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-05-03 | 417 | $0.00 | 417 | $6.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2027-10-27 | No | 4 | M | Direct | |
| 13,750 | 2028-01-19 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
- 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
Billionaire Hedge Funds
